| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 10/14/2009 | CN101555249A Method for synthesizing famciclovir |
| 10/14/2009 | CN100549013C Method for synthesizing 2-amido-6-chloropurine |
| 10/13/2009 | US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 10/13/2009 | US7601835 Preparation of famciclovir and other purine derivatives |
| 10/13/2009 | US7601723 For treating asthma and improving insulin sensitivity |
| 10/13/2009 | US7601713 Kinase inhibitors and their uses |
| 10/13/2009 | CA2341678C Potassium channel inhibitors and method |
| 10/13/2009 | CA2222513C Agents binding specifically to biotin for detecting damaged nucleic acid bases |
| 10/08/2009 | WO2009123881A1 Purine derivatives as a3 receptor- selective agonists |
| 10/08/2009 | CA2720037A1 Purine derivatives as a3 adenosine receptor-selective agonists |
| 10/07/2009 | EP0840736B1 Improved synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions |
| 10/07/2009 | CN101550137A Method for synthesizing famciclovir |
| 10/06/2009 | US7598379 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |
| 10/01/2009 | WO2009121036A2 Substituted aryl pyrimidinone derivatives |
| 10/01/2009 | WO2009118759A2 Heterocyclic compounds as adenosine receptor antagonist |
| 10/01/2009 | WO2009086077A3 A1 adenosine receptor antagonists |
| 10/01/2009 | US20090247749 Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
| 10/01/2009 | US20090247556 Azolopyrimidines as Inhibitors of Cannabinoid 1 Activity |
| 10/01/2009 | US20090247538 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors |
| 10/01/2009 | US20090247517 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 10/01/2009 | US20090247487 Combination Therapy to Treat Hepatitis B Virus |
| 10/01/2009 | US20090246818 Compounds, methods, complexes, apparatuses and uses relating to stabile forms of nad/nadh |
| 10/01/2009 | CA2718983A1 Heterocyclic compounds as adenosine receptor antagonist |
| 09/30/2009 | CN101544641A Novel anticancer-active purine nucleoside compounds modified by monoazacrown ether at 6-position and preparation method thereof |
| 09/30/2009 | CN101543497A Methods of treating patients suffering from movement disorders |
| 09/29/2009 | US7595401 6-amino-9H-purines as anticancer agents; 9-[2-(1-Acetylpiperridin-4-yl)ethyl]-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-6-amine for example |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | CA2379560C Purine derivatives inhibitors of tyrosine protein kinase syk |
| 09/24/2009 | US20090239886 Substituted xanthine derivatives |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 09/23/2009 | EP2101741A2 Solid dispersion comprising a poorly water soluble drug |
| 09/23/2009 | EP1490015B1 Novel 2-amino-9-((2-hydroxymethyl) cyclopropylidenemethyl) purines as antiviral agents |
| 09/23/2009 | CN101538224A Process for preparing xanthine phosphodiesterase V inhibitors and precursers thereof |
| 09/22/2009 | US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists |
| 09/22/2009 | US7592449 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 09/22/2009 | US7592177 Compositions and methods for inducing cell dedifferentiation |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/17/2009 | US20090233947 2,3-Substituted fused bicyclic pyrimidin-4(3H)-ones which modulating the function of the vanilloid -1 receptor (VR1) |
| 09/17/2009 | US20090233946 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation |
| 09/17/2009 | US20090233872 Therapeutic Agent for Neurodegenerative Disease |
| 09/16/2009 | CN101531660A Industrialization production process of entecavir-monohydrate |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | CA2376835C Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| 09/15/2009 | CA2218561C Compounds and methods of use to treat infectious diseases |
| 09/11/2009 | WO2009086457A3 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions |
| 09/11/2009 | WO2009037473A3 Nucleobase characterisation |
| 09/10/2009 | US20090227596 Heteroaryl nitrile derivatives |
| 09/09/2009 | EP2097415A1 8-ethinylxanthine derivatives as selective a2a receptor antagonists |
| 09/09/2009 | CN100537569C Method for preparing adenine by hydrolyzing adenosine in high temperature liquid water without catalyst |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/03/2009 | WO2009108383A2 Substituted xanthine derivatives |
| 09/03/2009 | WO2009108375A1 Substituted xanthine derivatives |
| 09/03/2009 | WO2009003428A3 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | CA2716788A1 Substituted xanthine derivatives |
| 09/02/2009 | EP2094704A2 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 09/02/2009 | CN101522680A Process for the preparation of abacavir |
| 09/01/2009 | US7582758 producing cyclic phosphonic acid diesters prodrugs, used to improve the oral bioavailability; by reacting a chiral 1,3-diol and an activated phosphonic acid in the presence of a Lewis acid; Adefovir drug target delivery to liver |
| 09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
| 08/27/2009 | US20090215798 Inhibitor Compounds |
| 08/27/2009 | US20090215730 Antineoplastic compounds and pharmaceutical compositions thereof |
| 08/26/2009 | CN101516882A Selective antagonists of A2A adenosine receptors |
| 08/26/2009 | CN101516850A Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 08/25/2009 | US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system |
| 08/25/2009 | US7579348 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma |
| 08/25/2009 | US7579334 Compounds with anti-inflammatory activity |
| 08/25/2009 | CA2455097C Enzyme inhibition immunoassay based on impdh inhibition by mpa |
| 08/20/2009 | WO2009081105A3 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 08/20/2009 | US20090209561 Xanthine Derivatives with HM74A Receptor Activity |
| 08/20/2009 | US20090209557 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 08/20/2009 | US20090209535 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/20/2009 | US20090208456 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
| 08/19/2009 | EP1470114B1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 08/19/2009 | CN101511831A Adenosine derivatives as A2A receptor agonists. |
| 08/19/2009 | CN101508690A Novel methods for simultaneously extracting tea polyphenol, tea polysaccharide and caffeinum from tea |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/13/2009 | WO2009099221A1 Production method and production device for composition having high content of theobromine |
| 08/13/2009 | WO2009099110A1 Ultraviolet absorbent, fused ring compound and method for producing the same |
| 08/13/2009 | WO2009074575A3 Organic compounds |
| 08/13/2009 | US20090203636 Prevention and Treatment of Cancer and Other Diseases |
| 08/12/2009 | CN101506210A 2-phenoxy pyrimidinone analogues |
| 08/12/2009 | CN101506209A Kw-3902 conjugates that do not cross the blood-brain barrier |
| 08/12/2009 | CN101505762A Orally active purine-based inhibitors of heat shock protein 90 |
| 08/12/2009 | CN101503409A 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments |
| 08/12/2009 | CN101503408A 8-(3-amino-piperidin-1-yl)-xanthines |
| 08/12/2009 | CN100526315C N2-quinoline or isoquinoline substituted purine derivative and its preparation method and uses |
| 08/11/2009 | US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine |
| 08/11/2009 | US7572800 Administering anti-hepatitis B virus agents in combination or alternation such asbeta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl-1,3-oxathiolane or a salt and one another antihepatitis B agent |
| 08/11/2009 | CA2487033C Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/05/2009 | EP2085397A1 Crystalline form of abacavir |
| 08/05/2009 | EP2084161A1 Adenine derivatives as inhibitors of hsp90 for the treatment of cancer |
| 08/05/2009 | EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 08/05/2009 | CN101497615A Substituted purine, preparation and use in medicine |
| 08/05/2009 | CN100523199C Thermolabile caffeine fraction of tea leaves and an efficient method of introducing agrobacterium-mediated genetic transformation in plants |